Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 367

1.

Left ventricular structure and systolic function in African Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Nkomo VT, Arnett DK, Benjamin EJ, Liebson PR, Hutchinson RG, Skelton TN.

Ethn Dis. 2004 Autumn;14(4):483-8.

PMID:
15724766
2.

Echocardiographic left ventricular mass in African-Americans: the Jackson cohort of the Atherosclerosis Risk in Communities Study.

Skelton TN, Andrew ME, Arnett DK, Burchfiel CM, Garrison RJ, Samdarshi TE, Taylor HA, Hutchinson RG.

Echocardiography. 2003 Feb;20(2):111-20.

PMID:
12848675
3.

Left ventricular mass and systolic dysfunction in essential hypertension.

Schillaci G, Vaudo G, Pasqualini L, Reboldi G, Porcellati C, Verdecchia P.

J Hum Hypertens. 2002 Feb;16(2):117-22.

4.

Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women.

Nunez E, Arnett DK, Benjamin EJ, Oakes JM, Liebson PR, Skelton TN.

Am J Cardiol. 2004 Dec 1;94(11):1383-90.

PMID:
15566908
5.
6.

Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension.

Devereux RB, Roman MJ, Palmieri V, Okin PM, Boman K, Gerdts E, Nieminen MS, Papademetriou V, Wachtell K, Dahlöf B.

J Hypertens. 2000 Aug;18(8):1129-38.

PMID:
10954006
7.

Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).

Gerdts E, Zabalgoitia M, Björnstad H, Svendsen TL, Devereux RB.

Am J Cardiol. 2001 Apr 15;87(8):980-3; A4.

PMID:
11305990
8.

Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.

Wachtell K, Rokkedal J, Bella JN, Aalto T, Dahlöf B, Smith G, Roman MJ, Ibsen H, Aurigemma GP, Devereux RB.

Am J Cardiol. 2001 Jan 1;87(1):54-60.

PMID:
11137834
9.

Gender-specific brachial artery blood pressure-independent relationship between pulse wave velocity and left ventricular mass index in a group of African ancestry.

Libhaber E, Woodiwiss AJ, Libhaber C, Maseko M, Majane OH, Makaula S, Dessein P, Essop MR, Sareli P, Norton GR.

J Hypertens. 2008 Aug;26(8):1619-28. doi: 10.1097/HJH.0b013e328302ca27.

PMID:
18622241
10.
11.

Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.

Wachtell K, Palmieri V, Olsen MH, Bella JN, Aalto T, Dahlöf B, Gerdts E, Wright JT Jr, Papademetriou V, Mogensen CE, Borch-Johnsen K, Ibsen H, Devereux RB.

Am Heart J. 2002 Feb;143(2):319-26.

PMID:
11835038
12.

Relation of insulin to left ventricular geometry and function in African American and white hypertensive adults: the HyperGEN study.

Devereux RB, de Simone G, Palmieri V, Oberman A, Hopkins P, Kitzman DW, Rao DC, Arnett DK.

Am J Hypertens. 2002 Dec;15(12):1029-35.

PMID:
12460697
13.

Effect of regression of left ventricular hypertrophy from systemic hypertension on systolic function assessed by midwall shortening (HOT echocardiographic study).

Zabalgoitia M, Rahman SN, Haley WE, Yarows S, Krause L, Anderson LC, Oraby MA, Amarena J.

Am J Cardiol. 2001 Sep 1;88(5):521-5.

PMID:
11524061
14.

Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) Study.

Burchfiel CM, Skelton TN, Andrew ME, Garrison RJ, Arnett DK, Jones DW, Taylor HA Jr.

Circulation. 2005 Aug 9;112(6):819-27. Epub 2005 Aug 1.

15.

Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study.

Gardin JM, Siscovick D, Anton-Culver H, Lynch JC, Smith VE, Klopfenstein HS, Bommer WJ, Fried L, O'Leary D, Manolio TA.

Circulation. 1995 Mar 15;91(6):1739-48.

16.

Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.

Wachtell K, Papademetriou V, Smith G, Gerdts E, Dahlöf B, Engblom E, Aurigemma GP, Bella JN, Ibsen H, Rokkedal J, Devereux RB.

Am Heart J. 2004 Sep;148(3):538-44.

PMID:
15389245
17.

Left ventricular midwall mechanics in subjects with aortic stenosis and normal systolic chamber function.

Ballo P, Mondillo S, Motto A, Faraguti SA.

J Heart Valve Dis. 2006 Sep;15(5):639-50.

PMID:
17044369
18.
19.

Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy).

Cramariuc D, Rieck AE, Staal EM, Wachtell K, Eriksen E, Rossebø AB, Gerdts E.

Am J Cardiol. 2008 Feb 15;101(4):510-5. doi: 10.1016/j.amjcard.2007.09.100. Epub 2007 Dec 20.

PMID:
18312768
20.

Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS).

Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, Grimm R, Stamler J.

Circulation. 1993 Feb;87(2):476-86.

PMID:
8425295
Items per page

Supplemental Content

Write to the Help Desk